PMID- 24504124 OWN - NLM STAT- MEDLINE DCOM- 20141126 LR - 20211021 IS - 1791-2423 (Electronic) IS - 1019-6439 (Print) IS - 1019-6439 (Linking) VI - 44 IP - 4 DP - 2014 Apr TI - The roles of transforming growth factor-beta, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). PG - 1015-22 LID - 10.3892/ijo.2014.2286 [doi] AB - Primary liver tumours have a high incidence and mortality. The most important forms are hepatocellular carcinoma and intrahepatic cholangiocarcinoma, both can occur together in the mixed phenotype hepatocellular-cholangiocarcinoma. Liver progenitor cells (LPCs) are bipotential stem cells activated in case of severe liver damage and are capable of forming both cholangiocytes and hepatocytes. Possibly, alterations in Wnt, transforming growth factor-beta, Notch and hypoxia pathways in these LPCs can cause them to give rise to cancer stem cells, capable of driving tumourigenesis. In this review, we summarize and discuss current knowledge on the role of these pathways in LPC activation and differentiation during hepatocarcinogenesis. FAU - Bogaerts, Eliene AU - Bogaerts E AD - Department of Gastroenterology and Hepatology, 1K12, Ghent University Hospital, 9000 Gent, Belgium. FAU - Heindryckx, Femke AU - Heindryckx F AD - Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden. FAU - Vandewynckel, Yves-Paul AU - Vandewynckel YP AD - Department of Gastroenterology and Hepatology, 1K12, Ghent University Hospital, 9000 Gent, Belgium. FAU - Van Grunsven, Leo A AU - Van Grunsven LA AD - Department of Cell Biology, Liver Cell Biology Lab, Vrije Universiteit Brussel, 1090 Brussels, Belgium. FAU - Van Vlierberghe, Hans AU - Van Vlierberghe H AD - Department of Gastroenterology and Hepatology, 1K12, Ghent University Hospital, 9000 Gent, Belgium. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20140203 PL - Greece TA - Int J Oncol JT - International journal of oncology JID - 9306042 RN - 0 (Receptors, Notch) RN - 0 (Transforming Growth Factor beta) RN - 0 (Wnt Proteins) SB - IM MH - Bile Duct Neoplasms/pathology MH - Bile Ducts, Intrahepatic/pathology MH - Carcinoma, Hepatocellular/pathology MH - Cell Differentiation MH - Cell Hypoxia/*physiology MH - Cell Transformation, Neoplastic MH - Cholangiocarcinoma/pathology MH - Humans MH - Liver/pathology MH - Liver Neoplasms/pathology MH - Receptors, Notch/*metabolism MH - Stem Cells/cytology/*pathology MH - Transforming Growth Factor beta/*metabolism MH - Wnt Proteins/*metabolism MH - Wnt Signaling Pathway PMC - PMC3977811 EDAT- 2014/02/08 06:00 MHDA- 2014/12/15 06:00 PMCR- 2014/02/03 CRDT- 2014/02/08 06:00 PHST- 2013/10/25 00:00 [received] PHST- 2013/11/28 00:00 [accepted] PHST- 2014/02/08 06:00 [entrez] PHST- 2014/02/08 06:00 [pubmed] PHST- 2014/12/15 06:00 [medline] PHST- 2014/02/03 00:00 [pmc-release] AID - ijo-44-04-1015 [pii] AID - 10.3892/ijo.2014.2286 [doi] PST - ppublish SO - Int J Oncol. 2014 Apr;44(4):1015-22. doi: 10.3892/ijo.2014.2286. Epub 2014 Feb 3.